Inviting an author to review:
Find an author and click ‘Invite to review selected article’ near their name.
Search for authorsSearch for similar articles
18
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Anti-Infective and Antiviral Activity of Valinomycin and Its Analogues from a Sea Cucumber-Associated Bacterium, Streptomyces sp. SV 21

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The manuscript investigated the isolation, characterization and anti-infective potential of valinomycin ( 3), streptodepsipeptide P11A ( 2), streptodepsipeptide P11B ( 1), and one novel valinomycin analogue, streptodepsipeptide SV21 ( 4), which were all produced by the Gram-positive strain Streptomyces cavourensis SV 21. Although the exact molecular weight and major molecular fragments were recently reported for compound 4, its structure elucidation was not based on compound isolation and spectroscopic techniques. We successfully isolated and elucidated the structure based on the MS 2 fragmentation pathways as well as 1H and 13C NMR spectra and found that the previously reported structure of compound 4 differs from our analysis. Our findings showed the importance of isolation and structure elucidation of bacterial compounds in the era of fast omics technologies. The here performed anti-infective assays showed moderate to potent activity against fungi, multi drug resistant (MDR) bacteria and infectivity of the Hepatitis C Virus (HCV). While compounds 2, 3 and 4 revealed potent antiviral activity, the observed minor cytotoxicity needs further investigation. Furthermore, the here performed anti-infective assays disclosed that the symmetry of the valinomycin molecule is most important for its bioactivity, a fact that has not been reported so far.

          Related collections

          Most cited references21

          • Record: found
          • Abstract: found
          • Article: not found

          Sharing and community curation of mass spectrometry data with Global Natural Products Social Molecular Networking.

          The potential of the diverse chemistries present in natural products (NP) for biotechnology and medicine remains untapped because NP databases are not searchable with raw data and the NP community has no way to share data other than in published papers. Although mass spectrometry (MS) techniques are well-suited to high-throughput characterization of NP, there is a pressing need for an infrastructure to enable sharing and curation of data. We present Global Natural Products Social Molecular Networking (GNPS; http://gnps.ucsd.edu), an open-access knowledge base for community-wide organization and sharing of raw, processed or identified tandem mass (MS/MS) spectrometry data. In GNPS, crowdsourced curation of freely available community-wide reference MS libraries will underpin improved annotations. Data-driven social-networking should facilitate identification of spectra and foster collaborations. We also introduce the concept of 'living data' through continuous reanalysis of deposited data.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Natural Products as Sources of New Drugs from 1981 to 2014.

            This contribution is a completely updated and expanded version of the four prior analogous reviews that were published in this journal in 1997, 2003, 2007, and 2012. In the case of all approved therapeutic agents, the time frame has been extended to cover the 34 years from January 1, 1981, to December 31, 2014, for all diseases worldwide, and from 1950 (earliest so far identified) to December 2014 for all approved antitumor drugs worldwide. As mentioned in the 2012 review, we have continued to utilize our secondary subdivision of a "natural product mimic", or "NM", to join the original primary divisions and the designation "natural product botanical", or "NB", to cover those botanical "defined mixtures" now recognized as drug entities by the U.S. FDA (and similar organizations). From the data presented in this review, the utilization of natural products and/or their novel structures, in order to discover and develop the final drug entity, is still alive and well. For example, in the area of cancer, over the time frame from around the 1940s to the end of 2014, of the 175 small molecules approved, 131, or 75%, are other than "S" (synthetic), with 85, or 49%, actually being either natural products or directly derived therefrom. In other areas, the influence of natural product structures is quite marked, with, as expected from prior information, the anti-infective area being dependent on natural products and their structures. We wish to draw the attention of readers to the rapidly evolving recognition that a significant number of natural product drugs/leads are actually produced by microbes and/or microbial interactions with the "host from whence it was isolated", and therefore it is considered that this area of natural product research should be expanded significantly.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Chemical ecology of antibiotic production by actinomycetes.

              Actinomycetes are a diverse family of filamentous bacteria that produce a plethora of natural products relevant for agriculture, biotechnology and medicine, including the majority of the antibiotics we use in the clinic. Rather than as free-living bacteria, many actinomycetes have evolved to live in symbiosis with among others plants, fungi, insects and sponges. As a common theme, these organisms profit from the natural products and enzymes produced by the actinomycetes, for example, for protection against pathogenic microbes, for growth promotion or for the degradation of complex natural polymers such as lignocellulose. At the same time, the actinomycetes benefit from the resources of the hosts they interact with. Evidence is accumulating that these interactions control the expression of biosynthetic gene clusters and have played a major role in the evolution of the high chemical diversity of actinomycete-produced secondary metabolites. Many of the biosynthetic gene clusters for antibiotics are poorly expressed under laboratory conditions, but they are likely expressed in response to host-specific demands. Here, we review the environmental triggers and cues that control natural product formation by actinomycetes and provide pointers as to how these insights may be harnessed for drug discovery.
                Bookmark

                Author and article information

                Contributors
                Role: Academic Editor
                Role: Academic Editor
                Journal
                Mar Drugs
                Mar Drugs
                marinedrugs
                Marine Drugs
                MDPI
                1660-3397
                02 February 2021
                February 2021
                : 19
                : 2
                : 81
                Affiliations
                [1 ]Institute for Chemistry and Biology of the Marine Environment (ICBM), Carl-von-Ossietzky University Oldenburg, Schleusenstraße 1, D-26382 Wilhelmshaven, Germany; matthias.kellermann@ 123456uni-oldenburg.de
                [2 ]Research Center for Biotechnology, Indonesian Institute of Science, Jl. Raya Bogor KM 46, Cibinong 16911, Indonesia; mast001@ 123456lipi.go.id (M.Y.P.); tuti007@ 123456lipi.go.id (T.M.); Dimas.Praditya@ 123456ruhr-uni-bochum.de (D.F.P.)
                [3 ]Alfred-Wegener-Institut für Polar- und Meeresforschung in der Helmholtz-Gemeinschaft, Am Handelshafen 12, 27570 Bremerhaven, Germany; Matthias.Koeck@ 123456awi.de
                [4 ]Helmholtz Centre for Infection Research, Inhoffenstraße 7, 38124 Braunschweig, Germany; kathrinmohr4@ 123456gmail.com (K.I.M.); joachim.wink@ 123456helmholtz-hzi.de (J.W.)
                [5 ]TWINCORE-Centre for Experimental and Clinical Infection Research (Institute of Experimental Virology) Hannover, Feodor-Lynen-Str. 7-9, 30625 Hannover, Germany; Eike.Steinmann@ 123456ruhr-uni-bochum.de
                [6 ]Department of Molecular and Medical Virology, Ruhr-University Bochum, 44801 Bochum, Germany
                [7 ]Helmholtz Institute for Functional Marine Biodiversity at the University of Oldenburg (HIFMB), Ammerländer Heerstrasse 231, D-26129 Oldenburg, Germany
                Author notes
                [* ]Correspondence: joko.tri.wibowo@ 123456uni-oldenburg.de (J.T.W.); peter.schupp@ 123456uni-oldenburg.de (P.J.S.); Tel.: +49-4421-944-100 (P.J.S.)
                Author information
                https://orcid.org/0000-0003-3467-6263
                https://orcid.org/0000-0002-9879-3293
                https://orcid.org/0000-0001-9675-0276
                https://orcid.org/0000-0003-4831-2751
                Article
                marinedrugs-19-00081
                10.3390/md19020081
                7912928
                33540548
                9a41096e-72ac-47ca-a8ea-25b0d238ce91
                © 2021 by the authors.

                Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ( http://creativecommons.org/licenses/by/4.0/).

                History
                : 04 December 2020
                : 28 January 2021
                Categories
                Article

                Pharmacology & Pharmaceutical medicine
                cyclodepsipeptides,marine actinobacteria,streptomyces spp.,antibiotic,sea cucumber,hcv

                Comments

                Comment on this article

                scite_
                0
                0
                0
                0
                Smart Citations
                0
                0
                0
                0
                Citing PublicationsSupportingMentioningContrasting
                View Citations

                See how this article has been cited at scite.ai

                scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

                Similar content188

                Cited by8

                Most referenced authors384